Back to Results
First PageMeta Content
Biology / Gynaecological cancer / HPV vaccine / Cervarix / Human papillomavirus / Cervical cancer / AS04 / Immunogenicity / Vaccination / Papillomavirus / Medicine / Vaccines


Statistical Review and Evaluation
Add to Reading List

Open Document

File Size: 86,78 KB

Share Result on Facebook

Company

GlaxoSmithKline Biologicals / Glaxosmithkline plc / /

Country

Germany / Canada / /

Event

FDA Phase / /

IndustryTerm

prevention of the following diseases / /

MedicalCondition

cervical intraepithelial neoplasia / diseases / CIN / HPV / cervical cancer / adenocarcinoma / /

MedicalTreatment

vaccination / /

Organization

FDA / sBLA Review Committee / REVIEW COMMITTEE / /

Person

Estelle Russek-Cohen / A. Dale Horne / Helen Gemignani / Nancy Miller / P.H. HFM / /

Position

Team Leader / external statistician / General / Regulatory Project Manager Chair / Executive / Chief / /

Product

HFM-217 / CERVARIX / HPV-048 / /

ProgrammingLanguage

ML / /

Technology

firewall / antibodies / /

SocialTag